🟢 Outlook Therapeutics is trading 5.7% up today amid biotech sector rebound

Outlook Therapeutics is trading 5.7% up today at $1.01 as shares rebound alongside a broader lift in the biotechnology sector.

• The stock continues to recover following a late-July rally driven by FDA developments and a subsequent period of consolidation.
• Today's upward momentum appears driven by positive risk-on sentiment in the sector, with the SPDR S&P Biotech ETF (XBI) gaining approximately 2%.
• There are no new company-specific announcements or regulatory updates today to account for the price action.